New pill aims to silence stubborn cough
NCT ID NCT05733533
First seen Jan 24, 2026 · Last updated May 15, 2026 · Updated 15 times
Summary
This study tested an experimental drug called HRS-2261 in 97 adults with refractory chronic cough (a cough lasting over a year that doesn't respond to usual treatments). Participants received either the drug or a placebo for 4 weeks. The main goal was to see if the drug reduces cough severity and improves quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY CHRONIC COUGH are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510120, China
Conditions
Explore the condition pages connected to this study.